New Type 2 Diabetes Treatment Synjardy® (empagliflozin/metformin hydrochloride) Tablets Now Available in U.S. Pharmacies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. SPY
4. META
5. MU
6. NVDA
7. BLZE
8. IBM
9. PRIM
10. ACN

Go back to New Type 2 Diabetes Treatment Synjardy® (empagliflozin/metformin hydrochloride) Tablets Now Available in U.S. Pharmacies
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1107.98 +5.90 (0.54%)
Previous Close $1102.08    52 Week High $88.16 
Open $1117.00    52 Week Low $67.88 
Day High $1122.02    P/E 256.48 
Day Low $1079.22    EPS $4.32 
Volume 2,662,463